Sign up now!
Don't show this again
Sweepstakes Rules

We’re glad you’re enjoying Poultry Health Today.
Access is free but you’ll need to register to view more content.
Already registered? Sign In
Tap to download the app
REPORTSCollect articles and features into your own report to read later, print or share with others

Create a New Report


Read Later

Create a new report

Report title (required) Brief description (optional)
follow us

You must be logged in to edit your profile.

Sponsored by Zoetis

Sponsored By Zoetis


Campylobacter research reveals potential for poultry vaccine

Researchers at the USDA Richard B. Russell Agricultural Research Center have purified proteins from Campylobacter and tested them for their potential use as vaccines. One protein showed particular promise and future studies will focus on determining whether it can be used as a practical in-ovo vaccine.

Campylobacter jejuni, commonly associated with poultry, causes human campylobacteriosis. Hung-Yueh Yeh, Kelli Hiett, J. Eric Line and Bruce Seal of the USDA Richard B. Russell Agricultural Research Center at Athens, Georgia explain in their report that although many strategies for reducing C. jejunicontamination in poultry have been examined, there are currently no practical intervention means available for the poultry industry to effectively reduce the contamination of C. jejuni during production and processing. Therefore, research for practical on-farm interventions is an urgent need.

In this proposal for the US Poultry and Egg Association, the group approached this problem by development of C. jejuni sub-unit proteins as potential vaccines for broilers.

The hypothesis of the proposed study was that expression of a battery ofC. jejuni proteins involved in colonisation has the potential for discovery of novel antigen(s) that can be used for in-ovo vaccination to reduce the bacterium in broiler chicken gastrointestinal systems.

The specific objectives of this proposal were to

  1. construct a system for expressing large amounts of important C. jejuni proteins
  2. produce and purify the recombinant C. jejuni proteins
  3. assay the immune response in broiler chickens against these C. jejuni proteins, and
  4. conduct vaccination experiments with the C. jejuni proteins.

Objective 1

Fifty-seven C. jejuni genes potentially involved in colonisation were identified. Twenty-eight genes were successfully over-expressed to allow purification of proteins.

Objective 2

The proteins were purified using chromatography.

Objective 3

Two recombinant proteins – flagellar capping protein (FliD) and methyl-accepting chemotaxis protein (Cjj0473) reacted strongly to sera from broilers older than six weeks of age in the preliminary experiments, indicating that these were antigens which the broiler immune system was exposed to and responding to in the field.

Next, the researchers evaluated whether sera collected from other areas in the US contained antibodies against the FliD protein. Sera from layer breeders at 44 to 52 weeks of age showed 100 per cent positive, while sera from broilers at four to six weeks of age from 22 premises showed seven to 100 per cent positives.

These results suggest that C. jejuni was widespread in these poultry populations, and chickens had been exposed to this microorganism. It appears that prevalence of C. jejuni in these poultry populations was age-related.

Objective 4

Three in-ovo experiments were conducted. The results showed very poor hatchability, suggesting that the adjuvant used was toxic to chicken embryos. Next, one-day-old maternal antibody-positive broiler chickens were vaccinated with 100mg per chicken of the FliD protein prepared with an equal amount of incomplete Freund’s adjuvant. The broiler chicks responded by producing antibody to the protein.

These results suggest that the FliD protein is immunogenic in broilers and that this protein has potential as a vaccine candidate. The results also indicate that maternal antibodies may not affect immunisation.


Yeh and colleagues conclude their results have following potential impacts for the industry.

They found that this protein is present in all 21 C. jejuni isolates and is immunogenic in broilers. Therefore, this protein will be an excellent candidate for further evaluation as a vaccine to reduce Campylobacter in poultry.

In addition, antibodies to this protein may be used for as a tool to monitor the Campylobacter status during poultry production. Currently, C. jejuni is regarded as a commensal in the chicken gut intestine, which does not harm chickens. The Athens studies, however, demonstrated that broiler sera reacted to a variety of Campylobacter proteins, suggesting that chickens had been exposed to or infected with this microorganism, and consequently developed antibodies against it.

Further, they showed antibodies against the FliD protein were widespread in poultry populations. Therefore, control of Campylobacter exposure through vaccination of chickens is a logical approach to Campylobacter control, and the FliD protein is a good vaccine candidate.

Further studies must be done to evaluate the use of this protein by in-ovoapplication to determine its potential practical use and efficacy, added Yeh and colleagues.



Article courtesy of thepoultrysite.com

Posted on September 19, 2014

tags: , ,

You must be logged in to edit your profile.

Google Translate is provided on this website as a reference tool. However, Poultry Health Today and its sponsor and affiliates do not guarantee in any way the accuracy of the translated content and are not responsible for any event resulting from the use of the translation provided by Google. By choosing a language other than English from the Google Translate menu, the user agrees to withhold all liability and/or damage that may occur to the user by depending on or using the translation by Google.